 |
||||
|
RESEARCH FACULTY
Ph.D., Department of Haematology, Queen's University, Belfast, Ireland Selected Publications: Zhan F, Huang Y, Colla S, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Holmig K, Zangarri M, Pineada-Roman M, Van Rhee F, Burington B, John Crowley J, Tricot G, Barlogie B, and Shaughnessy Jr. J. The Molecular Classification of Multiple Myeloma, Blood, 108:2020-8 (2006). Hanamura I, Stewart JP, Huang Y, Zhan F, Santra M, Sawyer J, Holmig K, Zangarri M, Pineada-Roman M, Van Rhee F, Cavallo F, Burington B, John Crowley J, Tricot G, Barlogie B, and Shaughnessy Jr. J. Frequent Gain of Chromosome Band 1q21 in Plasma Cell Dyscrasias Detected by Fluorescence In Situ Hybridization: Incidence Increases from MGUS to Relapsed Myeloma and is Related to Prognosis and Disease Progression Following Tandem Stem Cell Transplantation. Blood, 108:1724-32 (2006) Carrasco R, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, Zhan F, Deepak Khatry D, Protopopova M, Protopopov A, Sukhdeo K, Hanamura I, Stephens O, Barlogie B, Anderson K, Chin L, Shaughnessy Jr. J, Brennan C and DePinho R. High-resolution genomic profiles defines distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell. 4:313-25 (2006) Stewart JP, Shaughnessy JD Jr. Role of Osteoblast Suppression in multiple myeloma. J Cell Biochem. 2006 May 1: 98(1): 1-13. Review Stewart JP, Thompson A, Santra M, Barlogie B, Lappin TR, Shaughnessy J Jr. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma. Br J Haematol. 2004 Jul;126(1):72-6.
About Multiple Myeloma // About the Myeloma Institute // Becoming a Patient Highlights of Our Myeloma Program // Our Physician Team // Our Nursing Team News/Events/Press Releases // Scientific Publications/Research About Little Rock & Arkansas // About UAMS // About The Winthrop P. Rockefeller Cancer Institute Travel/Directions/Maps // Contact Us // Make a Donation
Having problems
with the site? E-mail the Webmaster. The information on the Myeloma Institute web site is not intended as a substitute for professional medical attention. The information is intended only as an aid in understanding current medical knowledge. A physician should always be consulted for any health concern or medical condition. The Myeloma Institute web site provides links to other organizations as a service to our readers. The Myeloma Institute is not responsible for the information provided on other web sites. Notice of Privacy Practices |
|
||
James Peter Stewart, Ph.D.